Horizon Pharma plc 4
4 · Horizon Pharma plc · Filed Jun 15, 2016
Insider Transaction Report
Form 4
Nohria Virinder
Director
Transactions
- Sale
Ordinary Shares
2016-06-15$17.69/sh−25,000$442,280→ 189,836 total
Holdings
- 5,258(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.65 to $17.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.